In recent years, advancements in cancer treatment have enabled cancer cell inhibition, leading to improved patient outcomes. This study's findings may contribute to developing effective interventions targeting chemotherapy-related neutropenia among patients with breast cancer in clinical practice.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via PubMed.
| Category | 🧬 Medicine & Biology |
| Published | Mar 11, 2024 |
| Journal | JMIR research protocols |
| Authors | Wang Kai-Hung, Shen Hsuan-Shu, Chu Sung-Chao, Wang Tso-Fu, Lin Ching-Wei |
| DOI | 10.2196/55662 |
| Source | PubMed |